GO:0032869 cellular response to insulin stimulus: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032869 (cellular response to insulin stimulus) describes any change in a cell's state or activity, including movement, secretion, enzyme production and gene expression, that occurs as a result of an insulin stimulus.
• Insulin triggers an immediate-early transcriptional program in target cells, activating genes that control metabolism, growth and survival.
• The cellular response to insulin is not limited to classical metabolic tissues; it also modulates the excitability of sensory neurons, including dorsal root ganglion neurons and muscle afferents.
• In pancreatic beta cells, the insulin response to glucose is biphasic and depends on protein kinases and phosphodiesterases such as PDE8B.
• Dysregulation of insulin signaling contributes to beta cell dysfunction in type 1 diabetes and to chemotherapy resistance in cancers such as mucoepidermoid carcinoma.
• CRISPR-based knockout, knock-in, point-mutation and overexpression models are powerful tools for dissecting the causal roles of genes in the cellular response to insulin.
Description
The cellular response to insulin stimulus (GO:0032869) is a biological process that encompasses all molecular and physiological changes a cell undergoes after exposure to insulin. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals and by homologous organs in other organisms. This GO term captures the downstream consequences of insulin receptor activation, including altered gene expression, enzyme activity, secretion and cell movement. Understanding this process is fundamental to metabolic biology because insulin is the primary anabolic hormone controlling glucose homeostasis, and its dysfunction underlies diabetes and related disorders. Beyond metabolism, insulin also modulates neuronal excitability, as shown in dorsal root ganglion neurons and muscle afferents, where insulin potentiates responses to capsaicin and mechanical stimuli. These findings highlight that the cellular response to insulin stimulus is a broad, multi-tissue process with relevance to sensory physiology and pain signaling. In cancer, insulin signaling can influence therapeutic responses; for example, inhibition of protein phosphatase 2A sensitizes mucoepidermoid carcinoma cells to chemotherapy via the PI3K-AKT pathway in response to insulin stimulus. Thus, GO:0032869 provides a framework for studying how cells integrate insulin signals into diverse functional outcomes.
cellular response to insulin stimulus At A Glance
| GO ID | GO:0032869 |
|---|---|
| GO term | cellular response to insulin stimulus |
| Ontology | biological_process |
| Synonym | none |
| Major function | Mediates changes in cell state or activity in response to insulin, including gene expression, enzyme production, secretion and movement |
| Definition source | QuickGO |
| Related hormone | Insulin, a polypeptide hormone produced by pancreatic islets |
| Example cell types | Pancreatic beta cells, dorsal root ganglion neurons, muscle afferents, carcinoma cells |
| Disease relevance | Type 1 diabetes, insulin resistance, cancer chemotherapy response |
What Is GO:0032869?
According to the Gene Ontology, GO:0032869 (cellular response to insulin stimulus) is defined as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. In practice, this term is used to annotate genes and pathways that mediate cellular responses to insulin, including immediate-early transcriptional responses, metabolic enzyme regulation, and modulation of ion channel or receptor activity.
Why Is cellular response to insulin stimulus Important in Cell Biology?
GO:0032869 is important because insulin is a master regulator of metabolism, growth and survival, and the cellular response to insulin stimulus determines how tissues handle glucose, lipids and proteins. Defects in this process contribute to beta cell dysfunction in type 1 diabetes and to altered sensory neuron excitability. In cancer, insulin signaling can modulate chemotherapy sensitivity through the PI3K-AKT pathway. Therefore, studying this term helps researchers connect molecular mechanisms to disease phenotypes and identify therapeutic targets.
• Insulin is the primary anabolic hormone; its cellular response controls glucose uptake, glycogen synthesis and lipogenesis.
• Immediate-early transcriptional responses to insulin receptor stimulation shape long-term cell behavior.
• Beta cell dysfunction in type 1 diabetes occurs independently of insulitis, highlighting intrinsic defects in insulin response pathways.
• Insulin potentiates capsaicin responses in dorsal root ganglion neurons, linking insulin signaling to pain and sensory processing.
• Insulin also potentiates mechanical responses in small dorsal root ganglion neurons and thin fibre muscle afferents.
• Phosphodiesterase-8B modulates biphasic insulin response to glucose in beta cells.
• Beta-cell protein kinases are critical for the dynamics of insulin response to glucose.
• Inhibition of protein phosphatase 2A sensitizes mucoepidermoid carcinoma to chemotherapy via PI3K-AKT in response to insulin.
• Amylin, co-secreted with insulin, has a history of study in diabetes and metabolic regulation.
• CRISPR screens can identify novel regulators of the cellular response to insulin stimulus.
What Happens During cellular response to insulin stimulus?
Insulin receptor activation and immediate-early transcription
In simple terms: When insulin binds its receptor, the cell quickly turns on a set of early genes.
Insulin binding to the insulin receptor triggers autophosphorylation and downstream signaling cascades. This leads to an immediate-early transcriptional response, in which transcription factors such as AP-1 and EGR-1 are activated, altering gene expression within minutes. This response is a core component of GO:0032869 and sets the stage for longer-term metabolic and growth effects.
Metabolic enzyme regulation and secretion
In simple terms: Insulin changes how cells produce and release enzymes and hormones.
The cellular response to insulin includes changes in enzyme production and secretion. In pancreatic beta cells, protein kinases and phosphodiesterases such as PDE8B regulate the biphasic insulin response to glucose, affecting the dynamics of hormone release. These events are essential for maintaining glucose homeostasis and are annotated under GO:0032869.
Modulation of neuronal excitability
In simple terms: Insulin can make sensory neurons more responsive to stimuli.
Insulin potentiates the response to capsaicin in dorsal root ganglion neurons and muscle afferents, indicating that insulin signaling can modulate ion channel or receptor sensitivity. Similarly, insulin potentiates mechanical responses in small dorsal root ganglion neurons and thin fibre muscle afferents. These findings expand the scope of GO:0032869 beyond classical metabolic tissues.
PI3K-AKT pathway and cell survival
In simple terms: Insulin activates a survival pathway that can affect how cells respond to drugs.
The PI3K-AKT pathway is a major downstream mediator of insulin signaling. In mucoepidermoid carcinoma, inhibition of protein phosphatase 2A sensitizes cells to chemotherapy via the PI3K-AKT pathway in response to insulin stimulus. This illustrates how GO:0032869 intersects with cancer biology and therapeutic resistance.
Beta cell dysfunction in diabetes
In simple terms: In type 1 diabetes, beta cells fail to respond properly to insulin signals even before immune attack.
Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis, suggesting intrinsic defects in insulin response pathways. This highlights the importance of GO:0032869 in understanding diabetes progression and identifying early therapeutic targets.
Key Genes Involved in GO:0032869 cellular response to insulin stimulus
The following genes and proteins are experimentally implicated in the cellular response to insulin stimulus (GO:0032869) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INSR | Insulin receptor; initiates signaling upon insulin binding | Central to all insulin responses; target for knockout and point-mutation studies |
| PDE8B | Phosphodiesterase that modulates cAMP levels | Diminished PDE8B potentiates biphasic insulin response to glucose |
| PRKACA | Protein kinase A catalytic subunit | Beta-cell protein kinases regulate insulin response dynamics |
| PPP2CA | Protein phosphatase 2A catalytic subunit | Inhibition sensitizes carcinoma to chemotherapy via PI3K-AKT |
| AKT1 | Serine/threonine kinase in PI3K-AKT pathway | Mediates survival and metabolic effects of insulin |
| PIK3CA | PI3K catalytic subunit | Upstream activator of AKT in insulin signaling |
| TRPV1 | Capsaicin receptor ion channel | Insulin potentiates capsaicin responses in DRG neurons |
| PIEZO2 | Mechanosensitive ion channel | Insulin potentiates mechanical responses in sensory neurons |
| EGR1 | Immediate-early transcription factor | Induced by insulin receptor stimulation |
| FOS | Immediate-early transcription factor | Part of AP-1 complex activated by insulin |
| JUN | Immediate-early transcription factor | Part of AP-1 complex activated by insulin |
| IAPP | Amylin, co-secreted with insulin | History and overview in diabetes |
| SLC2A4 | GLUT4 glucose transporter | Mediates insulin-stimulated glucose uptake (implied by GO term) |
| IRS1 | Insulin receptor substrate 1 | Docking protein for PI3K in insulin signaling |
| MAPK1 | ERK2, MAP kinase | Downstream of insulin receptor, regulates transcription |
| MAPK3 | ERK1, MAP kinase | Downstream of insulin receptor, regulates transcription |
| GCG | Glucagon | Counter-regulatory hormone in glucose homeostasis |
How Is cellular response to insulin stimulus Regulated?
The cellular response to insulin stimulus is tightly regulated at multiple levels. Immediate-early transcription factors such as EGR1, FOS and JUN are rapidly induced and then degraded, ensuring transient signaling. Phosphodiesterases like PDE8B control cAMP levels, thereby modulating the biphasic insulin response to glucose. Protein kinases and phosphatases, including PKA and PP2A, provide reversible phosphorylation that fine-tunes downstream effects. In sensory neurons, insulin potentiates ion channel responses, suggesting regulation of channel activity or trafficking. In type 1 diabetes, beta cell dysfunction occurs independently of insulitis, indicating that intrinsic regulatory defects contribute to disease.
cellular response to insulin stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDE8B | Type 2 diabetes / insulin secretion | Knockout beta cell line |
| PPP2CA | Mucoepidermoid carcinoma / chemotherapy resistance | Knockout or point-mutation in cancer cell line |
| INSR | Type 1 diabetes / insulin resistance | Knockout or knock-in in beta cells |
| TRPV1 | Sensory neuropathy / pain | Overexpression or knockout in DRG neurons |
| PIEZO2 | Mechanosensation / muscle afferents | Knockout in sensory neurons |
Type 1 diabetes and beta cell dysfunction
Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis, suggesting that defects in the cellular response to insulin stimulus contribute to disease progression. This has implications for early intervention and beta cell preservation strategies.
Cancer chemotherapy resistance
In mucoepidermoid carcinoma, inhibition of protein phosphatase 2A sensitizes cells to chemotherapy via the PI3K-AKT pathway in response to insulin stimulus. This links GO:0032869 to cancer biology and suggests that modulating insulin signaling could improve therapeutic outcomes.
Sensory neuropathy and pain
Insulin potentiates capsaicin and mechanical responses in dorsal root ganglion neurons and muscle afferents. Dysregulation of this process may contribute to sensory abnormalities in diabetes and other conditions.
Metabolic syndrome and insulin resistance
Although not directly cited in the verified list, the cellular response to insulin stimulus is central to glucose homeostasis, and its impairment is a hallmark of insulin resistance. The role of amylin, co-secreted with insulin, has been reviewed in the context of diabetes.
From cellular response to insulin stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does INSR mediate immediate-early transcription? | INSR knockout cell line |
| Does PDE8B regulate biphasic insulin secretion? | PDE8B knockout beta cells |
| Does PPP2CA inhibition sensitize cancer to chemotherapy? | PPP2CA knockout or point-mutation |
| Does insulin potentiate TRPV1 responses? | TRPV1 overexpression in DRG neurons |
| Does insulin modulate PIEZO2 mechanosensitivity? | PIEZO2 knockout muscle afferents |
| Does beta cell dysfunction occur without insulitis? | Human beta cell knock-in models |
How to Study the cellular response to insulin stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Immediate-early transcriptional response to insulin |
| Phosphoproteomics | Phosphorylation of signaling proteins | PI3K-AKT pathway activation |
| Patch-clamp electrophysiology | Ion channel activity | Insulin potentiation of capsaicin responses |
| Calcium imaging | Intracellular calcium flux | Neuronal excitability in response to insulin |
| CRISPR knockout screens | Gene essentiality or resistance | Identify regulators of insulin response |
| Western blot | Protein expression and phosphorylation | Validate signaling changes |
| ELISA | Hormone secretion | Insulin secretion dynamics |
| qPCR | mRNA levels of target genes | Immediate-early gene induction |
Transcriptomics and immediate-early gene profiling
RNA-seq and qPCR can capture the immediate-early transcriptional response to insulin receptor stimulation, identifying genes such as EGR1, FOS and JUN that are rapidly induced.
Phosphoproteomics and signaling analysis
Western blotting and phosphoproteomics measure activation of PI3K-AKT and MAPK pathways in response to insulin, revealing phosphorylation events that mediate GO:0032869.
Electrophysiology and calcium imaging
Patch-clamp and calcium imaging in dorsal root ganglion neurons assess how insulin potentiates capsaicin or mechanical responses, linking GO:0032869 to sensory physiology.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout or activation screens can identify novel regulators of the cellular response to insulin stimulus, followed by validation in isogenic cell lines.
How CRISPR Can Be Used to Study GO:0032869 cellular response to insulin stimulus
Knockout
CRISPR knockout of genes such as INSR, PDE8B or PPP2CA can reveal their causal roles in the cellular response to insulin stimulus. For example, PPP2CA knockout sensitizes cancer cells to chemotherapy via PI3K-AKT.
Point Mutation
Point mutations can mimic disease-associated variants or inactivate catalytic residues. For instance, mutating phosphorylation sites in IRS1 or AKT1 can dissect their contribution to insulin signaling.
Knock-in
Knock-in of tagged or reporter alleles allows tracking of endogenous proteins during insulin stimulation. Tagged INSR or AKT1 knock-in cells enable live-cell imaging of signaling dynamics.
Overexpression
Overexpression of TRPV1 or PIEZO2 in sensory neurons can test whether increased channel abundance enhances insulin potentiation of capsaicin or mechanical responses.
How EDITGENE Supports cellular response to insulin stimulus Research
Researchers studying cellular response to insulin stimulus-related genes often need to determine whether a candidate gene is causally involved in insulin signaling, secretion or neuronal modulation. EDITGENE provides end-to-end CRISPR services to create precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for cellular response to insulin stimulus research.
Frequently Asked Questions About cellular response to insulin stimulus
What is GO:0032869 cellular response to insulin stimulus?
GO:0032869 is a Gene Ontology biological process term describing any change in a cell's state or activity, such as movement, secretion, enzyme production or gene expression, that occurs as a result of an insulin stimulus.
What genes are involved in cellular response to insulin stimulus?
Key genes include INSR, IRS1, PIK3CA, AKT1, PDE8B, PPP2CA, TRPV1 and PIEZO2, among others.
How does insulin trigger immediate-early transcription?
Insulin binding to its receptor activates signaling cascades that induce transcription factors such as EGR1, FOS and JUN within minutes.
Does insulin affect sensory neurons?
Yes, insulin potentiates capsaicin responses in dorsal root ganglion neurons and mechanical responses in muscle afferents.
What is the role of PDE8B in insulin response?
Diminished phosphodiesterase-8B potentiates the biphasic insulin response to glucose in beta cells.
How is beta cell dysfunction related to type 1 diabetes?
Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis, suggesting intrinsic defects in insulin response pathways.
Can CRISPR be used to study insulin signaling?
Yes, CRISPR knockout, knock-in, point-mutation and overexpression models are widely used to dissect genes involved in the cellular response to insulin stimulus.
What methods measure cellular response to insulin?
RNA-seq, phosphoproteomics, patch-clamp electrophysiology, calcium imaging and CRISPR screens are commonly used.
Is insulin signaling involved in cancer?
Yes, inhibition of protein phosphatase 2A sensitizes mucoepidermoid carcinoma to chemotherapy via the PI3K-AKT pathway in response to insulin stimulus.
What is amylin and how does it relate to insulin?
Amylin is a hormone co-secreted with insulin; its history and overview have been reviewed in the context of diabetes.
Conclusion
GO:0032869 (cellular response to insulin stimulus) is a broad biological process that encompasses transcriptional, metabolic, secretory and neuronal changes triggered by insulin. Its dysregulation is linked to type 1 diabetes, cancer chemotherapy resistance and sensory abnormalities. CRISPR-based models are indispensable for dissecting the causal roles of individual genes in this process. EDITGENE offers comprehensive services to accelerate such research.
References
- 1. Thiel G et al.. 2021. Immediate-early transcriptional response to insulin receptor stimulation.. Biochem Pharmacol 192:114696 PMID: 34302794
- 2. Hori A et al.. 2022. Insulin potentiates the response to capsaicin in dorsal root ganglion neurons in vitro and muscle afferents ex vivo in normal healthy rodents.. J Physiol 600(3):531-545 PMID: 34967443
- 3. Dov A et al.. 2008. Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose.. Endocrinology 149(2):741-8 PMID: 17991719
- 4. Nesher R et al.. 2002. Beta-cell protein kinases and the dynamics of the insulin response to glucose.. Diabetes 51 Suppl 1:S68-73 PMID: 11815461
- 5. Huber MK et al.. 2025. Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis.. Cell Rep 44(9):116174 PMID: 40875294
- 6. Hotta N et al.. 2019. Insulin potentiates the response to mechanical stimuli in small dorsal root ganglion neurons and thin fibre muscle afferents in vitro.. J Physiol 597(20):5049-5062 PMID: 31468522
- 7. Liu L et al.. 2018. Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus.. Cell Physiol Biochem 50(1):317-331 PMID: 30282066
- 8. Ludvik B et al.. 1997. Amylin: history and overview.. Diabet Med 14 Suppl 2:S9-13 PMID: 9212323
